{
  "url": "https://openlegislation.uk/eu-directive-2004-33/annex-III/division-2/division-2.2/division-2.2.1/division-1",
  "json_url": "https://openlegislation.uk/eu-directive-2004-33/annex-III/division-2/division-2.2/division-2.2.1/division-1.json",
  "legislation": "eudr/2004/33",
  "legislation_title": "Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-directive-2004-33",
  "path": "annex/III/division/2/division/2.2/division/2.2.1/division/1",
  "kind": "division",
  "number": null,
  "heading": "Duration of deferral period",
  "text": "After an infectious illness, prospective donors shall be deferred for at least two weeks following the date of full clinical recovery.\nHowever, the following deferral periods shall apply for the infections listed in the table:\nBrucellosis (*)\n2 years following the date of full recovery\nOsteomyelitis\n2 years after confirmed cured\nQ fever (*)\n2 years following the date of confirmed cured\nSyphilis (*)\n1 year following the date of confirmed cured\nToxoplasmosis (*)\n6 months following the date of clinical recovery\nTuberculosis\n2 years following the date of confirmed cured\nRheumatic fever\n2 years following the date of cessation of symptoms, unless evidence of chronic heart disease\nFever > °C\n2 weeks following the date of cessation of symptoms\nFlu-like illness\n2 weeks after cessation of symptoms\nMalaria (*)\n—\nindividuals who have lived in a malarial area within the first five years of life\n3 years following return from last visit to any endemic area, provided person remains symptom free;\nmay be reduced to 4 months if an immunologic or molecular genomic test is negative at each donation\n—\nindividuals with a history of malaria\n3 years following cessation of treatment and absence of symptoms.\nAccept thereafter only if an immunologic or molecular genomic test is negative\n—\nasymptomatic visitors to endemic areas\n6 months after leaving the endemic area unless an immunologic or molecular genomic test is negative\n—\nindividuals with a history of undiagnosed febrile illness during or within six months of a visit to an endemic area\n3 years following resolution of symptoms;\nmay be reduced to 4 months if an immunologic or molecular test is negative\nWest Nile Virus (WNV) (*)\n28 days after leaving a risk area of locally acquired West Nile Virus unless an individual Nucleic Acid Test (NAT) is negative",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "F",
      "label": "F1",
      "text": "Substituted by Commission Directive 2014/110/EU of 17 December 2014 amending Directive 2004/33/EC as regards temporary deferral criteria for donors of allogeneic blood donations (Text with EEA relevance)."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eudr/2004/33/annex/III/division/2/division/2.2/division/2.2.1/division/1",
    "retrieved_at": "2026-11-01T15:22:49.438638+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}